Sort
172,184 grants matching “inflammation”
Pulmonary pathophysiology sub-phenotypes of pneumonia
$805,021Joseph P Mizgerd · Boston University Medical Campus · R01 · FY2024 · AI
An integrative omics approach to investigate gene-environment interaction in colorectal cancer risk
$804,978Ulrike Peters · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Viral and Host Dynamics during Pediatric COVID-19 and Respiratory Virus Co-Infection
$804,976Judd F Hultquist · Northwestern University At Chicago · R01 · FY2024 · AI
Signal Transduction In B Lymphocytes: Identification Of Key Signaling Molecules
$804,943John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Human Respiratory Tract Microbiome in Health, HIV Infection and HIV Lung Disease
$804,838Ronald G Collman · University Of Pennsylvania · U01 · FY2010 · HL
Role of B Lymphocytes In HIV Infection And Pathogenesis
$804,809Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Immune Cells in Alzheimerâs Disease and Related Dementias in the Jackson Heart Study
$804,770Laura M Raffield · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AG
Murine models of vascular remodeling
$804,763Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Light, metabolic syndrome and Alzheimerâs disease: a non-pharmacological approach
$804,753Mariana Gross Figueiro · Rensselaer Polytechnic Institute · R01 · FY2019 · AG
Defining the pathogenic relationship of TDP-43 inclusions and cytoplasmic double stranded RNA in AD and FTD
$804,740Mark W Albers · Harvard Medical School · R01 · FY2025 · AG
Limited Competition: Frequent Hemodialysis Network (U01)
$804,740Nathan W Levin · Renal Research Institute, Llc · U01 · FY2009 · DK
Methamphetamine and Cysteinyl Leukotrienes in HIV Persistence
$804,728Marcus Kaul · University Of California Riverside · R01 · FY2025 · DA
T Cell Differentiation
$804,708B. Fowlkes · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Dominantly Inherited Alzheimer Network: Project 3
$804,703Anne Fagan Niven · Washington University · U19 · FY2021 · AG
COVID-19-related blood-brain barrier and microstructural brain injury; Sex differences and synergy with Alzheimer's disease risk
$804,670Emilie T. Reas · University Of California, San Diego · R01 · FY2023 · AG
Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease
$804,669Jin Wang · Baylor College Of Medicine · U01 · FY2024 · AG
Eradication of latent SIV from the CNS
$804,637Andrew G Maclean · Tulane University Of Louisiana · R01 · FY2020 · NS
Basic Cardiovascular Research Training Grant
$804,623Gary K Owens · University Of Virginia · T32 · FY2015 · HL
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments (Vestibulodynia: UPDATe)
$804,598Andrea G Nackley · Duke University · R01 · FY2018 · HD
Study of Women's Health Across the Nation (SWAN V): Michigan Site
$804,598Sioban D Harlow · University Of Michigan At Ann Arbor · U01 · FY2014 · NR
Human Respiratory Tract Microbiome in Health, HIV Infection and HIV Lung Disease
$804,577Ronald G Collman · University Of Pennsylvania · U01 · FY2011 · HL
A Multilevel Investigation of Migration and Dementia Risk Among Mexican Americans
$804,568Adina Zeki Al Hazzouri · Columbia University Health Sciences · R01 · FY2025 · AG
VISTA is a negative checkpoint regulator of innate immunity
$804,549Randolph J. Noelle · Dartmouth College · R01 · FY2021 · AI
Role of Peripheral Immune Cells in Cognitive Aging: The Framingham Offspring Study
$804,541Joanne M Murabito · Boston University Medical Campus · R01 · FY2020 · AG
Host genetic predictors of plasma IL-1b levels and pharmacogenomics of in vivo IL-1b blockade during treated HIV disease
$804,532Sulggi Angela Lee · University Of California, San Francisco · R01 · FY2021 · AI